Basic Information | Post buying leads | Suppliers |
Name |
TERGITOL XH |
EINECS | N/A |
CAS No. | 106392-12-5 | Density | g/cm3 |
PSA | 46.15000 | LogP | 3.33230 |
Solubility | N/A | Melting Point |
57-61 °C |
Formula | (C3H6O•C2H4O)x | Boiling Point | 32.9°Cat760mmHg |
Molecular Weight | 332.48 | Flash Point | 55.2°C |
Transport Information | N/A | Appearance | N/A |
Safety | Low toxicity by ingestion and skin contact. When heated to decomposition it emits acrid smoke and irritating vapors. | Risk Codes | 61 |
Molecular Structure | Hazard Symbols | T | |
Synonyms |
TERGITOL(TM)XH(NONIONIC);f108;f127;f77;f87;f88;methyloxiranepolymerwithoxiraneblock;oxirane,methyl-,polymerwithoxirane,block |
IUPAC Name: 2-Methyloxirane ; Oxirane
The MF of Poloxamer (CAS NO.106392-12-5) is C5H10O2.
The MW of Poloxamer (CAS NO.106392-12-5) is 102.13.
Synonyms of Poloxamer (CAS NO.106392-12-5): 1,2-Propyleneglycol, ethoxylated and propoxylated
Enthalpy of Vaporization: 27.35 kJ/mol
Flash Point: 55.2 °C
Boiling Point: 32.9 °C
Poloxamer (CAS NO.106392-12-5) is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 420mg/kg (420mg/kg) | Journal of Pharmacy and Pharmacology. Vol. 34(Suppl), Pg. 533, 1982. | |
mouse | LD50 | intravenous | 129mg/kg (129mg/kg) | Acute Toxicity Data. Journal of the American College of Toxicology, Part B. Vol. 12, Pg. 569, 1993. | |
mouse | LD50 | intravenous | 1gm/kg (1000mg/kg) | Microvascular Research. Vol. 8, Pg. 320, 1974. | |
mouse | LD50 | intravenous | 3gm/kg (3000mg/kg) | Drugs in Japan Vol. 6, Pg. 797, 1982. | |
mouse | LD50 | oral | > 30300ug/kg (30.3mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 23, Pg. 2291, 1981. | |
mouse | LD50 | oral | 1830mg/kg (1830mg/kg) | Journal of Pharmacy and Pharmacology. Vol. 34(Suppl), Pg. 533, 1982. | |
mouse | LD50 | oral | 15gm/kg (15000mg/kg) | Bollettino Chimico Farmaceutico. Vol. 101, Pg. 173, 1962. | |
mouse | LD50 | subcutaneous | 5500mg/kg (5500mg/kg) | Drugs in Japan Vol. 6, Pg. 797, 1982. | |
mouse | LD50 | unreported | 400mg/kg (400mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 530mg/kg (530mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 750mg/kg (750mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 830mg/kg (830mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 1250mg/kg (1250mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 1400mg/kg (1400mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 2250mg/kg (2250mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 2700mg/kg (2700mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 3gm/kg (3000mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 3750mg/kg (3750mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | 4200mg/kg (4200mg/kg) | United States Patent Document. Vol. #4043344, | |
mouse | LD50 | unreported | > 5gm/kg (5000mg/kg) | United States Patent Document. Vol. #4043344, | |
rabbit | LD50 | skin | > 5gm/kg (5000mg/kg) | Union Carbide Data Sheet. Vol. 7/14/1965, | |
rat | LD50 | intraperitoneal | 320mg/kg (320mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LIVER: OTHER CHANGES BEHAVIORAL: ATAXIA | National Technical Information Service. Vol. OTS0540972, |
rat | LD50 | intraperitoneal | 1140mg/kg (1140mg/kg) | Journal of Pharmacy and Pharmacology. Vol. 34(Suppl), Pg. 533, 1982. | |
rat | LD50 | intravenous | 7500mg/kg (7500mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 1204, 1981. | |
rat | LD50 | oral | > 30300ug/kg (30.3mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 23, Pg. 2291, 1981. | |
rat | LD50 | oral | 2300mg/kg (2300mg/kg) | Journal of Pharmacy and Pharmacology. Vol. 34(Suppl), Pg. 533, 1982. | |
rat | LD50 | oral | 5gm/kg (5000mg/kg) | VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA | Wyandotte Chemicals Corporation Reports. |
rat | LD50 | oral | 5gm/kg (5000mg/kg) | VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA | Wyandotte Chemicals Corporation Reports. |
rat | LD50 | oral | 5gm/kg (5000mg/kg) | VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Wyandotte Chemicals Corporation Reports. |
rat | LD50 | oral | 9380mg/kg (9380mg/kg) | "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972Vol. -, Pg. 297, 1972. | |
rat | LD50 | oral | 22400mg/kg (22400mg/kg) | Union Carbide Data Sheet. Vol. 7/14/1965, | |
rat | LD50 | subcutaneous | 6900mg/kg (6900mg/kg) | Drugs in Japan Vol. 6, Pg. 797, 1982. |
Low toxicity by ingestion and skin contact. When heated to decomposition it emits acrid smoke and irritating vapors.